11740 Results

People

  1. Vickers
    Vickers
  2. Offit
    Offit
  3. Robson
    Robson
  4. Horwitz
    Horwitz
  5. Kingham
    Kingham
  6. Panageas
    Panageas
  7. Breitbart
    Breitbart
  8. Halpern
    Halpern
  9. Jarnagin
    Jarnagin
  10. Nelson
    Nelson

Groups

  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)
  7. Psychiatry and Behavioral Sciences, Department of (2780)
  8. Biostatistics Service (2339)
  9. GSK Faculty (2008)
  10. Health Outcomes Research Group (1948)
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3306)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (235)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11740)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long term outcome of peripheral T cell lymphomas: 10y follow‐up analysis of the International Prospective T Cell Project Network
    Meeting Abstract

    Civallero, M.; Advani, R.; Horwitz, S.; Manni, M.; Cabrera, M. E.; Vose, J.; Spina, M.; Hits, F.; Nagler, A.; Montoto, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: Outcomes by baseline histology
    Meeting Abstract

    Mehta‐Shah, N.; Jacobsen, E. D.; Zinzani, P. L.; Zain, J.; Mead, M.; Casulo, C.; Gritti, G.; Pinter‐Brown, L.; Izutsu, K.; Waters, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Mature T and NK cell lymphomas classified according to 2016 WHO classification. A report of 741 cases registered in the International Prospective T‐cell Project 2.0
    Meeting Abstract

    Manni, M.; Chiattone, C. S.; Prince, M. H.; Pavlovsky, A.; Tomuleasa, C.; Miranda, E.; Kriachok, I.; Hawkes, E. A.; Fiad, L.; Hitz, F.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • AFM13 in patients with CD30 positive relapsed or refractory (R/R) peripheral T cell lymphoma (PTCL): Results from the phase 2 redirect study
    Meeting Abstract

    Kim, W. S.; Shortt, J.; Zinzani, P. L.; Mikhaylova, N.; Marin‐Niebla, A.; Radeski, D.; Ribrag, V.; Domenech, E. D.; Sawas, A.; Alexis, K.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • BRCA1/2 mutations impact on the development of breast implant‐associated lymphoma (BIA‐ALCL) in women with breast cancer reconstructed with textured breast implants
    Meeting Abstract

    Ghione, P.; Arcila, M.; Joseph, V.; Dogan, A.; Cordeiro, P.; Salles, G.; de Jong, D.; Horwitz, S.; Mandelker, D.; van Leeuwen, F.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • The impact of cancer-related financial toxicity on reproductive concerns and family-building decision-making in post-treatment survivorship
    Journal Article

    Benedict, C.; Thom, B.; Diefenbach, M.; Schapira, L.; Simon, P.; Ford, J. S.
    Journal of Adolescent and Young Adult Oncology (2023)

    Fulltext@MSK | Save
  • Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions
    Journal Article

    Lindström, S.; Wang, L.; Feng, H. L.; Majumdar, A.; Huo, S. J.; Macdonald, J.; Harrison, T.; Turman, C.; Chen, H.; Mancuso, N.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Grading pancreatic neuroendocrine tumors via endoscopic ultrasound-guided fine needle aspiration: A multi-institutional study
    Journal Article

    Javed, A. A.; Pulvirenti, A.; Razi, S.; Zheng, J.; Michelakos, T.; Sekigami, Y.; Thompson, E.; Klimstra, D. S.; Deshpande, V.; Singhi, A. D.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save